Founded Nov 2014 in Shanghai, CARsgen is a leading CAR-T immunotherapy company in China and the Asia Pacific Area.
A rising global leader based in China, CARsgen is committed to fulfilling medical needs across the seas, focusing on treating orphan diseases in the West with high frequencies in Asia Pacific areas.
One of the first companies to conduct FIM clinical trials of CAR-T therapy for solid tumors, CARsgen aims to deliver first-in-class, innovative CAR-T therapies, empowering patients and their families to win the fight against cancer.
388 Yindu Road, Building BShanghai, ChinaT: 86-21-64501828
© CARsgen Therapeutics 2017